J.M. Borah, P. Chowdhury / Steroids 76 (2011) 1341–1345
1345
2.13. 3b-Hydroxy-17-oxa-5a-Androstan-16-one (10a)
168.9. IR (CHCl3): 1766, 1250, 950 cmÀ1; MS (m/z): 136 (M+). Anal.
Calcd. for C8H8O2: C, 70.57; H, 5.92. Found: C, 70.54; H, 5.90.
Melting point (m.p.) 164–168 °C; 1H NMR (300 MHz, CDCl3): 0.9
(s, 3H); 1.1 (s, 3H); 0.9–2.1 (m, 21H, CH&CH2); 2.2 (m, 2H); 3.8 (m,
1H); 13C NMR (CDCl3): d = 36.2 (C-1); 28.2 (C-2): 72.9 (C-3); 33.1
(C-4); 40.9 (C-5); 27.2 (C-6); 31.7 (C-7); 37.1 (C-8); 56.9 (C-9);
36.5 (C-10); 19.8 (C-11); 38.2 (C-12); 74.9 (C-13); 53.5 (C-14);
35.9 (C-15); 43.1 (C-16); 178.2 (C-17). IR (CHCl3): 3200, 1739,
1400, 1250, 950 cmÀ1; MS (m/z): 306 (M+). Anal. Calcd. for
References
[1] Baeyer A, Villiger V. Chem Ber 1899;32:3625–33.
[2] Ten Brink GJ, Arends IWCE, Sheldon RA. Chem Rev 2004;104:4105–23.
[3] Harmata M, Rashatasakhon P. Tetrahedron Lett 2002;43:3641–4.
[4] Crudden C, Chen AC, Calhoun LA. Angew Chem Int Ed 2000;30:2851–5.
[5] Renz M, Meunier B. Eur J Org Chem 1999:737–50.
[6] Goodman R, Kishi Y. J Am Chem Soc 1998;120:9392–3.
[7] (a) Krow GR. Org React 1993;43:251–798;
C19H30O3: C, 74.47; H, 9.87. Found: C, 74.45; H, 9.84.
(b) Krow GR. Compr Org Synth 1991:671–88.
2.14. 3b,17b-Acetoxy-5 ,6 -epoxy-5 -Androstane (11a)
a
a
a
[8] Alvarez-Idaboy JR, Reyes L, Cruz J. Org Lett 2006;8:1763–5.
[9] Grein F, Chen AC, Edwards D, Crudden CM. J Org Chem 2006;71:861–72.
[10] Carlqvist P, Eklund R, Brink T. J Org Chem 2001;66:1193–9.
[11] Djerassi C. In: Steroid reactions: an outline for organic chemists. Holden-Day
Inc.: San Francisco; 1963. p. 457.
[12] Blickenstaff RT. In: Antitumor steroids. Academic Press: New York; 1992. p.
81–90.
[13] Seagaloff A, Meyers KD, Rongone E, Weethy JB, Cunningham M. Cancer
(Philadelphia) 1962;15:636–40.
[14] Petrow V, Padilla GM. Novel approaches to cancer chemotherapy. In: Sunkara
PS, editor. Academic Press: New York; 1984. p. 269–305.
[15] Zoppi S, Coconi M, Natali A, Constantine A, Seiro M, Martini L, et al. Clin
Endocrin Metab 1986;63:269–71.
[16] Cepa MMDS, Tavares de Silva EJ, Correia-da-Silva G, Roleira FMF, Teixeria NAA.
J Med Chem 2005;48:6379–85.
Melting point (m.p.) 150–154 °C; 1H NMR (300 MHz, CDCl3): 0.9
(s, 3H); 1.1 (s, 3H); 2.1 (bs, 6H); 0.8–2.09 (m, 19H, CH&CH2); 3.8
(m, 1H); 4.5 (m, 2H); 13C NMR (CDCl3): d = 34.2 (C-1); 28.2 (C-2);
62.9 (C-3); 33.1 (C-4); 71.2 (C-5); 57.8 (C-6); 31.7 (C-7); 37.1 (C-
8); 55.9 (C-9); 36.5 (C-10); 19.8 (C-11); 38.2 (C-12); 41.3 (C-13);
53.5 (C-14); 20.9 (C-15); 31.1 (C-16); 73.2 (C-17); 171.3 (C–
OCOCH3); 17.2 (C–CH3COO). IR (CHCl3): 1735, 1400, 1250,
950 cmÀ1; MS (m/z): 390 (M+). Anal. Calcd. for C23H34O5: C,
70.74; H, 8.78. Found: C, 70.73; H, 8.75.
2.15. 4-Nor-3-oxo-4-oxa-5a-Cholestane (12a)
[17] Djurendic EA, Sakac MN, Zavis MP, Gakovic AR, Canadi JJ, Andric SA, et al.
Steroids 2008;73:681–8.
[18] Chowdhury P, Borah JM, Goswami P, Das AM. Steroids 2011;76:497–501.
[19] Chowdhury P, Das AM, Goswami P. Steroids 2005;70:494–8.
[20] Borah P, Chowdhury PK. J Chem Res (S) 1996:502–3.
Melting point (m.p.) 113–116°; 1H NMR (300 MHz, CDCl3): 0.8 (s,
3H); 1.1 (s, 3H); 0.8–2.1 (m, 34H, CH&CH2); 2.2 (m, 2H); 4.1 (q,
J = 3.5 Hz, 1H); 13C NMR (CDCl3): d = 36.2 (C-1); 28.2 (C-2); 173.1
(C-3); 86.1 (C-5); 24.8 (C-6); 25.7 (C-7); 29.8 (C-8); 42.6 (C-9);
37.8 (C-10); 20.9 (C-11); 34.5 (C-12); 40.5 (C-13); 51.4 (C-14);
30.7 (C-15); 26.9 (C-16); 43.9 (C-17); 18.7 (C-18); 15.4 (C-19);
39.1 (C-20); 15.8 (C-21); 35.7 (C-22); 24.6 (C-23); 39.7 (C-24);
28.3 (C-25); 22.6 (C-26); 22.8 (C-27). IR (CHCl3): 1735, 1400, 1250,
950 cmÀ1; MS (m/z): 388 (M+). Anal. Calcd. for C26H44O2: C, 80.35;
H, 11.41. Found: C, 80.32; H, 11.39.
[21] (a) Borah P, Ahmed M, Chowdhury PK.
J Chem Res (M) 1998:1173–8;
(b) Borah P, Ahmed M, Chowdhury PK. J Chem Res (S) 1998:236–8; (c)
Goswami P, Hazarika S, Borah P, Chowdhury PK. Ind
2003;42B:678–82.
J
Chem
[22] Hazarika S, Goswmi P, Chowdhury PK. Ind J Chem 2003;42B:1706–10.
[23] Chowdhury PK, Bordoloi MJ, Barua NC, Goswami PK, Sarmah HP, Sharma RP,
et al. US Pat. No: 5808,117.
[24] (a) Boyce R, Li G, Nestler HP, Suenaga T, Still WC.
1994;116:7955–6; (b) Cheng Y, Suenaga T, Still WC.
1996;118:1813–4.
J
J
Am Chem Soc
Am Chem Soc
[25] Madder A, Li L, De Muyunck H, Farcy N, Van Haver D, Fant F, et al. J Comb Chem
2002;4:552–62 [and references cited therein].
2.16. Phenyl benzoate (13a)
[26] Ding B, Taotofa U, Orsak T, Chadwell M, Savage PB. Org Lett 2004;6:3433–6.
[27] Goswami P, Hazarika S, Das AM, Chowdhury PK. Ind
2004;43B:1275–81.
J
Chem
Melting point (m.p.) 67–70 °C; 1H NMR (300 MHz, CDCl3):
6.8–7.2 (m, 5H), 7.6–8.2 (m, 5H); 13C NMR (CDCl3): d = 122.1;
126.4; 129.3; 130.9; 151.2; 173.1. IR (CHCl3): 1735, 1400, 1250,
950 cmÀ1; MS (m/z): 198 (M+). Anal. Calcd. for C13H10O2: C, 78.77;
H, 5.09. Found: C, 78.75; H, 5.06.
[28] Rothman ES, Wall MS, Eddy CR. J Am Chem Soc 1954;76:527–32.
[29] Koch SSC, Chamberlin AR. Syn Comm 1989;19:829–33.
[30] (a) Hamelin J, Bazureau J-P, Boullet FT. In: Loupy A, editor. Microwaves in
organic chemisry, 2nd ed. Wiley-VCH: Weinheim, Germany, 2003. p. 253
[chapter 8]; (b) de la Hoz A, Diaz-Ortiz A, Moreno A. Chem Soc Rev
2005;34:164; (c) Kappe CO, Chem Soc Rev 2008;37:1127.
[31] Bezdushna E, Ritter H. Macromol Rapid Commun 2007;28:443–8.
[32] Loupy A, Perreux L, Liagre M, Burle K, Moneuse M. Pure Appl Chem
2001;73:161–4.
2.17. Phenyl acetate (14a)
[33] Carsten K, Iannelli M, Kerep P, Klink M, Schmitz S, Sinnwell S, et al.
Tetrahedron 2006;62:4709–14.
[34] Riveria DG, Pando O, Suardiaz R, Coll F. Steroids 2007;72:466–73.
Melting point (m.p.) 195 °C; 1H NMR (300 MHz, CDCl3): 6.2–7.3
(m, 5H), 2.1 (s, 3H); 13C NMR (CDCl3): d = 20.3; 121.4; 126.2; 129.2;